Search Results - N.  Yu. Nikishina

Refine Results
  1. 1
    Osteoarthritis: Key elements in its pathogenesis and current agents for pathogenetic therapy

    Osteoarthritis: Key elements in its pathogenesis and current agents for pathogenetic therapy by Yu. A. Olyunin, N. Yu. Nikishina

    Published 2017-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Lupus panniculitis: diagnostic difficulties

    Lupus panniculitis: diagnostic difficulties by O. N. Egorova, N. Yu. Nikishina, B. S. Belov

    Published 2019-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Long-term belimumab therapy in patients with systemic lupus erythematosus

    Long-term belimumab therapy in patients with systemic lupus erythematosus by A. A. Mesnyankina, E. A. Aseeva, N. Yu. Nikishina

    Published 2024-08-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Personalized medicine: Predictors for the efficiency of biological agent therapy for rheumatoid arthritis

    Personalized medicine: Predictors for the efficiency of biological agent therapy for rheumatoid arthritis by M. A. Kotovskaya, N. Yu. Nikishina, Yu. A. Olyunin

    Published 2017-04-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    STRATEGY FOR DOSE REDUCTION AND DISCONTINUATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS REMISSION

    STRATEGY FOR DOSE REDUCTION AND DISCONTINUATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS REMISSION by M. A. Kotovskaya, N. Yu. Nikishina, Yu. A. Olyunin

    Published 2018-03-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus

    Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus by S. K. Solovyev, A. A. Mesnyankina, E. A. Aseeva, N. Yu. Nikishina

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case)

    Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case) by N. Yu. Nikishina, E. A. Aseeva, A. A. Mesnyankina, S. K. Soloviev

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Management of patients with systemic lupus erythematosus in real clinical practice

    Management of patients with systemic lupus erythematosus in real clinical practice by E. A. Aseeva, S. K. Soloviev, T. V. Popkova, N. Yu. Nikishina, A. A. Mesnyankina

    Published 2019-05-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data)

    Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data) by E. V. Ermolaeva, E. A. Aseeva, N. Yu. Nikishina, T. V. Popkova, A. M. Lila

    Published 2024-02-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality?

    Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality? by S. K. Soloviev, A. A. Mesnyankina, N. Yu. Nikishina, E. A. Aseeva, A. M. Lila

    Published 2022-02-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus

    Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus by N. Yu. Nikishina, E. A. Aseeva, S. K. Soloviev, A. M. Lila, A. V. Datcina, E. T. Pletnev

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab

    Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab by T. M. Reshetnyak, E. A. Aseeva, A. A. Shumilova, N. Yu. Nikishina, S. Yu. Shkireeva, A. M. Lila

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    The problem of fatigue in patients with systemic lupus erythematosus according to the data on a Russian RENAISSANCE cohort

    The problem of fatigue in patients with systemic lupus erythematosus according to the data on a Russian RENAISSANCE cohort by E. A. Aseeva, S. K. Solovyev, N. Yu. Nikishina, G. M. Koilubaeva, T. A. Lisitsyna, E. L. Nasonov

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Clinical and immunologic features of the phenotype of systemic lupus erythematosus combined with Sjögren's syndrome

    Clinical and immunologic features of the phenotype of systemic lupus erythematosus combined with Sjögren's syndrome by S. K. Solovyev, E. A. Aseeva, A. A. Baranov, A. M. Lila, N. Yu. Nikishina, S. I. Glukhova

    Published 2023-08-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Lupus nephritis – modern aspects of diagnosis and therapy. Part I

    Lupus nephritis – modern aspects of diagnosis and therapy. Part I by S. K. Solovyev, N. L. Kozlovskaya, E. A. Aseeva, A. A. Baranov, N. Yu. Nikishina, E. L. Nasonov

    Published 2024-03-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus

    Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus by A. A. Mesnyankina, S. K. Solovyev, N. Yu. Nikishina, E. A. Aseeva, N. V. Demidova, E. L. Nasonov

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study)

    Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study) by T. M. Reshetnyak, E. A. Aseeva, A. A. Shumilova, N.  Yu. Nikishina, S. I. Glukhova, S. Yu. Shkireeva, A. M. Lila

    Published 2024-04-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Forecasting index of unfavorable outcomes of systemic lupus erythematosus

    Forecasting index of unfavorable outcomes of systemic lupus erythematosus by E. A. Aseeva, N. Yu. Nikishina, A. A. Mesnyankina, S. K. Solovyev, B. Sh. Isaeva, G. M. Koilubaeva, A. M. Lila

    Published 2021-06-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY

    EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY by T. V. Beketova, M. A. Ushakova, N. Yu. Nikishina, A. N. Khelkovskaya-Sergeeva, E. V. Nikolaeva, E. G. Sazhina, T. M. Novoselova, E. L. Nasonov

    Published 2018-05-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    The first clinical experience with selective DNA plasmasorption using the NucleoCapture Device in the treatment of systemic lupus erythematosus

    The first clinical experience with selective DNA plasmasorption using the NucleoCapture Device in the treatment of systemic lupus erythematosus by E. A. Aseeva, N. S. Pokrovsky, S. K. Soloviev, E. V. Nikolaeva, N. Yu. Nikishina, E. T. Abdullin, T.  M. Reshetnyak, E. G. Zotkin, A. M. Lila

    Published 2024-04-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: